Philip Joseph Lopresti, M.D. Dermatology - Clinical & Laboratory Dermatological Immunology Medicare: Not Enrolled in Medicare Practice Location: 550 Norwood Rd, Mount Laurel, NJ 08054 Phone: 856-235-6020 Fax: 856-722-5675 |
Dr. Robert A Allen, M.D. Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 150 Century Pkwy Ste 105, Mount Laurel, NJ 08054 Phone: 856-206-0201 |
Dr. Robin Merle Levin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 101 Gaither Dr, Mount Laurel, NJ 08054 Phone: 215-588-3400 Fax: 856-810-9889 |
Dr. Albert Martin Dipasquale, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 813 East Gate Drive, Mount Laurel, NJ 08054 Phone: 856-222-9119 Fax: 856-222-9907 |
News Archive
A dramatic sea-change in research into ten so-called "neglected diseases," such as malaria, leprosy and sleeping sickness, could result in at least eight new drugs being developed by 2010.
Plexxikon Inc. today announced promising preclinical data from in vivo Alzheimer's Disease studies demonstrating a dramatic reduction in activated microglia in the brains of very old (22 months) 3xTG-AD mice, a triple transgenic model for Alzheimer's Disease. This reduction of activated microglia led to significantly improved learning in the treated group.
A novel catheter technique for patching holes in the heart may make it possible for many patients to avoid surgery altogether and others to regain enough strength to safely undergo surgical repair at a later date, according to a study reported at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, today announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the design of its planned Phase III registration clinical trial of Epanova™, the Company's lead compound for the treatment of patients with very high triglycerides. Epanova is an Omega 3 fatty acid containing a novel formulation of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Researchers at the University of Southern California will demonstrate how using wearable technology and smartphones can improve cancer treatment at a White House event on Oct. 3.
› Verified 7 days ago